Nabriva Therapeutics PLC (NASDAQ:NBRV)

1.41
Delayed Data
As of 3:59pm ET
 -0.07 / -4.73%
Today’s Change
1.16
Today|||52-Week Range
3.27
+6.82%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$147.0M

Company Description

Nabriva Therapeutics Plc is a clinical stage biopharmaceutical company, which engages in the research and development of novel antibiotics to treat serious infections. Its product pipeline includes Lefamulin, CONTEPO, and BC-7013. The company was founded in October 2005 and is headquartered in Dublin, Ireland.

Contact Information

Nabriva Therapeutics Plc
25-28 North Wall Quay
Dublin Dublin 1
P:(531) 649-2000
Investor Relations:

Employees

Shareholders

Mutual fund holders9.95%
Other institutional18.00%
Individual stakeholders11.97%

Top Executives

There are no executives to display.